Rationale: Twenty-eight percent of people with mild to moderate obstructive sleep apnea
experience daytime sleepiness, which interferes with daily functioning. It remains unclear …

Excessive daytime sleepiness (EDS) is a major symptom of obstructive sleep apnoea (OSA),
defined as the inability to stay awake during the day. Its clinical descriptors remain elusive …

Background Although highly effective in the treatment of obstructive sleep apnoea (OSA),
continuous positive airway pressure (CPAP) is not universally accepted by users …

Recent advances in obstructive sleep apnoea (OSA) pathophysiology and translational
research have opened new lines of investigation for OSA treatment and management. Key …

Background Although effective in the treatment of obstructive sleep apnoea (OSA),
continuous positive airway pressure (CPAP) does not meet with universal acceptance by …

Background: It is unclear whether continuous positive airway pressure (CPAP), the treatment
of choice for severe obstructive sleep apnoea (OSA), is effective at improving outcomes in …

Almost all the information about the effect of continuous positive airway pressure (CPAP) in
patients with obstructive sleep apnoea (OSA) comes from clinical trials involving only middle …

Background: Obstructive sleep apnea (OSA) is a common chronic disorder that often
requires lifelong care. Available practice parameters provide evidence-based …

Mandibular advancement devices (MADs) represent the main non-continuous positive
airway pressure (non-CPAP) therapy for patients with obstructive sleep apnoea (OSA). The …

Insomnia and sleep apnoea are the two most common sleep disorders, found in 6% and 23–
50% of the general population respectively. These disorders also frequently co-occur, with …